Using our expertise, understanding, and focus on the biological needs of cells in 3D biprinted constructs, we have created a novel bioink capable of printing hiPSC-derived neural cells that maintain high levels of cell viability for over a month.
Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better.
Viscofan BioEngineering is a business unit of Naturin Viscofan GmbH – a company of the Viscofan group. The modern production facilities including a plant for medical grade production are located in Weinheim, Germany. A dedicated international team covers the complete value chain from research to development and sales of novel collagen products.
The jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next-generation treatments and supporting current and future scientific research. At the heart of products is marine-sourced Collagen Type 0, evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.
The project Chiron is part of Eurostar, a european programme to foster R&D and international collaboration between companies and research institutes to create innovative products and technologies.
Chiron is an international collaboration between two SMEs (Concr3de BV and IPC,Innovative Polymer Compounds) and two research centers (University Medical Center of Utrecht and the Trinity College of Dublin).
The aim of the project is to create a fast multimaterial bioprinting platform for the research and production in the biomedical sector to create a portfolio of biomaterials and applications of the technology.
Humabiologics, Inc is a regenerative medicine startup founded by scientists and tissue industry experts with scientific, quality, regulatory and technology transfer expertise to address the gap between the gift of donated human tissues and researchers. Currently, the availability of human-derived biomaterials for regenerative therapies and research is limited due to unstable supply channels, low quality, and high prices. Humabiologics is dedicated to extending the gift of donation by developing and commercializing high quality, supply-stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. By stretching the gift of donation we strive to help as many people as possible with our unique product.
Allegro 3D is an emerging 3D printing and bioprinting company located in San Diego, a world hub for biotechnology. At the convergence of advanced additive manufacturing, stem cell biology and biomaterials, Allegro 3D’s expertise in bioprinting and biomaterials enables high-throughput manufacturing of advanced biomedical devices, cell matrices and precision human tissues for cell culture, drug screening, therapeutics and regenerative medicine.
Axolotl Biosystems creates high-resolution desktop 3D bioprinters and bioinks capable of producing functional three dimensional living tissues. Built to reduce the high costs of traditional 3D bioprinting systems, the accessibility to researchers and flexible open system architecture for construct design is making Axolotl Biosystems products the platform of choice for leading bioengineering laboratories around the world.
Founded in 2001, with technology out of the benchmarking collagen experts from United States, Sunmax has grown into a highly recognized, public-listed biomedical company in Taiwan. With the capability to develop, manufacture and market high standard collagen-base medical devices, Sunmax is dedicated to have more and more patients to benefit from our innovations in the field of regeneration.
A future for our children and grandchildren, whose medical care is governed and guided by health and not disease: Safe cell treatments and regenerative therapies that heal and save lives; humane and accessible to everyone. We have dedicated ourselves to regenerative medicine – ethical, responsible, visionary and passionate!
During the last few years, remarkable progress has been made in gene and cell therapy. Positive proof-of-principle results have been obtained for several diseases, such as adrenoleukodystrophy, hemophilia IX, β-thalassemia, malignant glioblastoma, leukemia and other types of cancer. Thus, it is expected that several new gene therapy products will enter the clinical arena in the not-so-distant future. In cell therapy, iPS cell technology has opened huge possibilities for cell therapy and regenerative medicine. There are still significant challenges in gene and cell therapy before these new approaches can enter main stream medicine. Significant safety issues have been reported in some trials and the need for better vectors, delivery techniques and treatment genes are widely recognized. With years of experience in providing high-quality products and services in the field of biopharmaceuticals for customers all over the world, scientists in Creative Biolabs will be more focused on developing first class product and technology to meet the need of stem cell therapy development.
We are a tech start-up based in Stockholm, Sweden. Akira Science provides pliable 3D-printed scaffolds for soft tissue engineering. Our customized scaffolds are the result of the combined expertise in degradable polymer synthesis, mechanical simulation and cell-material interaction.